Open AccessDutasteride in the long-term management of stuttering priapism
Author(s) -
Ryan C. Baker,
Rachel Bergeson,
Yooni Yi,
Ellen E. Ward,
Allen F. Morey
Publication year - 2020
Publication title -
translational andrology and urology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.721
H-Index - 27
eISSN - 2223-4691
pISSN - 2223-4683
DOI - 10.21037/tau.2019.07.15
Subject(s) - dutasteride , medicine , priapism , urology , dosing , erectile dysfunction , pediatrics , surgery , prostate , cancer
The objective of this study is to review our 12-year experience with the 5-α reductase inhibitor dutasteride as a potential long-term treatment option for stuttering priapism. Dutasteride has a uniquely long half-life of 35 days which offers a theoretical advantage as a chronic therapy for management of stuttering priapism.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom